CN110787258A - A Chinese medicinal composition for treating diabetes, and its preparation method - Google Patents
A Chinese medicinal composition for treating diabetes, and its preparation method Download PDFInfo
- Publication number
- CN110787258A CN110787258A CN201911181261.7A CN201911181261A CN110787258A CN 110787258 A CN110787258 A CN 110787258A CN 201911181261 A CN201911181261 A CN 201911181261A CN 110787258 A CN110787258 A CN 110787258A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- treating diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 54
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 58
- 239000002994 raw material Substances 0.000 claims abstract description 32
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 22
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 22
- 241000255789 Bombyx mori Species 0.000 claims abstract description 20
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 20
- 241000218989 Trichosanthes Species 0.000 claims abstract description 18
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 17
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 17
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 17
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 17
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 17
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 17
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 17
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 17
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 17
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 17
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 16
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 16
- 241000545744 Hirudinea Species 0.000 claims abstract description 15
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 13
- 241001289529 Fallopia multiflora Species 0.000 claims abstract description 11
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 5
- 244000046146 Pueraria lobata Species 0.000 claims description 18
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 17
- 239000011812 mixed powder Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 240000001341 Reynoutria japonica Species 0.000 claims description 10
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 244000293323 Cosmos caudatus Species 0.000 claims description 8
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 240000002948 Ophiopogon intermedius Species 0.000 claims 2
- 210000004369 blood Anatomy 0.000 abstract description 49
- 239000008280 blood Substances 0.000 abstract description 49
- 230000000694 effects Effects 0.000 abstract description 31
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000002124 endocrine Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- 239000008103 glucose Substances 0.000 description 17
- 244000132619 red sage Species 0.000 description 14
- 239000011049 pearl Substances 0.000 description 13
- 241001092040 Crataegus Species 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 244000248557 Ophiopogon japonicus Species 0.000 description 10
- 235000012054 meals Nutrition 0.000 description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 235000008434 ginseng Nutrition 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241000255791 Bombyx Species 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 241000180649 Panax notoginseng Species 0.000 description 6
- 235000003143 Panax notoginseng Nutrition 0.000 description 6
- 241000756042 Polygonatum Species 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 240000006023 Trichosanthes kirilowii Species 0.000 description 4
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 3
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 3
- 206010006895 Cachexia Diseases 0.000 description 3
- 241000218202 Coptis Species 0.000 description 3
- 235000002991 Coptis groenlandica Nutrition 0.000 description 3
- 241000237903 Hirudo Species 0.000 description 3
- 229930195210 Ophiopogon Natural products 0.000 description 3
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 3
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 208000026500 emaciation Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000032140 Sleepiness Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000037321 sleepiness Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 206010039020 Rhabdomyolysis Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 1
- 229960004346 glimepiride Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 231100000861 limb weakness Toxicity 0.000 description 1
- 208000027905 limb weakness Diseases 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 206010062198 microangiopathy Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229960001110 miglitol Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Abstract
The invention relates to the technical field of traditional Chinese medicine pharmacy, in particular to a traditional Chinese medicine composition for treating diabetes and a preparation method thereof. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 10-100 parts of red ginseng, 10-100 parts of pseudo-ginseng, 10-100 parts of leech, 10-100 parts of pearl, 10-100 parts of stiff silkworm, 10-100 parts of coptis chinensis, 10-100 parts of cinnamon, 10-100 parts of polygonum multiflorum, 10-100 parts of trichosanthes root, 10-100 parts of radix puerariae, 10-100 parts of salvia miltiorrhiza, 10-100 parts of radix ophiopogonis, 10-100 parts of rhizoma polygonati and 10-100 parts of hawthorn. The traditional Chinese medicine composition provided by the invention can obviously reduce the blood sugar of a diabetic patient, can prevent and treat various complications caused by diabetes, and has no toxic or side effect. In addition, the invention also has the functions of regulating endocrine, promoting blood circulation to remove blood stasis and improving the immunity of the diabetic, and solves the problems of low curative effect, temporary solution and permanent solution and larger side effect of the existing medicines for treating diabetes.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicine pharmacy, in particular to a traditional Chinese medicine composition for treating diabetes and a preparation method thereof.
Background
Diabetes mellitus is a chronic endocrine metabolic disease which causes disorder of metabolism of sugar, fat and protein due to insufficient secretion of insulin in a body, causes increase of blood sugar in the body and excretes diabetes. The clinical manifestations are polydipsia, diuresis, polyphagia, fatigue and emaciation. If further development is carried out, complications such as atherosclerosis, microangiopathy, nervous system and the like can be caused, and the health and the life of the human are threatened.
Diabetes is divided into two types, i.e., type I and type II. Type I is insulin dependent, and type II is non-insulin dependent. Among them, type II patients account for about 90% of the total number of diabetic patients, seriously threaten the health and life of people, and at present, there is no ideal medicine for treating both symptoms and root causes at home and abroad.
At present, most of the medicines for treating diabetes have certain curative effect, but most of the western medicines used clinically have large adverse reactions, such as rebound after stopping taking the medicines, liver and kidney damage of patients, rhabdomyolysis and other side effects, and are used for treating symptoms and not treating the root causes. The traditional Chinese medicine has unique advantages in the aspect of treating diabetes, has a plurality of traditional Chinese medicine prescriptions for preventing and treating diabetes, has a long-lasting curative effect, and mostly has no obvious toxic or side effect, but the traditional Chinese medicine for treating diabetes is mostly preferred to a single prescription and an proved prescription at present, and lacks of the clinical pharmacodynamic study with complete system. Therefore, based on the theory of traditional Chinese medicine and traditional Chinese medicine, the method has important significance in actively searching and making efforts to develop traditional Chinese medicines for treating diabetes (especially for treating type II diabetes) and preventing and treating various complications caused by diabetes according to the pathogenesis of diabetes.
Disclosure of Invention
The invention aims to solve the technical problem of providing a traditional Chinese medicine composition for treating diabetes and a preparation method thereof, and solves the problems that the existing medicine for treating diabetes has low curative effect, treats both symptoms and root causes, and has large side effect.
The technical scheme for solving the technical problems is as follows: a traditional Chinese medicine composition for treating diabetes comprises the following raw materials in parts by weight: 10-100 parts of red ginseng, 10-100 parts of pseudo-ginseng, 10-100 parts of leech, 10-100 parts of pearl, 10-100 parts of stiff silkworm, 10-100 parts of coptis chinensis, 10-100 parts of cinnamon, 10-100 parts of polygonum multiflorum, 10-100 parts of trichosanthes root, 10-100 parts of radix puerariae, 10-100 parts of salvia miltiorrhiza, 10-100 parts of radix ophiopogonis, 10-100 parts of rhizoma polygonati and 10-100 parts of hawthorn.
Red ginseng is warm in nature and sweet and bitter in taste, and has effects of regulating blood pressure, relieving fatigue, tranquilizing mind, nourishing brain, invigorating lung and spleen, invigorating kidney, tonifying yang, and preventing and treating cancer. The saponin contained in the red ginseng can obviously improve the hyperlipemia and can promote the metabolism of protein in a human body. Ginseng radix Rubri has effects of inhibiting hyperglycemia, invigorating qi, nourishing yin, replenishing blood, promoting fluid production, improving eyesight, tranquilizing mind, and regulating nerve. Ginseng radix Rubri can be used for treating thirst due to deficiency of body fluid, sexual impotence, and frequent micturition. In addition, Ginseng radix Rubri has effects of resisting diabetes and protecting retinopathy caused by diabetes. The argininyl-fructosyl-L-arginine diglycoside in Ginseng radix Rubri has effects of resisting diabetes and obesity, scavenging free radicals, and promoting microcirculation.
Notoginseng radix has sweet and slightly bitter taste, and has effects of dilating blood vessel, lowering blood pressure, improving blood circulation, and increasing blood flow. Simultaneously, can also prevent and treat the ischemic and anoxic diseases of heart and brain tissues, thereby regulating blood sugar, and reducing blood fat and cholesterol. In addition, Notoginseng radix can also inhibit arteriosclerosis, and has effects of promoting blood circulation and removing blood stasis.
The leech contains hirudin which has strong anticoagulation effect and can inhibit the activity of blood platelet in blood. Therefore, the leech-based medicament can be used for treating peripheral neuropathy, cardiovascular and cerebrovascular diseases, gastropathy and metabolic syndrome caused by diabetes.
The Margarita has effects of relieving palpitation, tranquilizing mind, removing toxic substance, promoting granulation, nourishing yin, expelling pathogenic wind, and improving eyesight, contains large amount of free calcium, can normalize calcium balance in human body, and can induce normal secretion of insulin, and the Margarita also has effect of inhibiting fatty acid production.
Bombyx Batryticatus contains a protein with stimulating effect on epinephrine, and can regulate endocrine and metabolism balance of patients.
The berberine contained in Coptidis rhizoma can promote regeneration of islet B cell, and has good therapeutic effect on type II diabetes. The berberine can obviously enhance the activity of liver superoxide dismutase, reduce the level of liver lipid peroxide and the content of serum triglyceride and total cholesterol, and has good curative effect on preventing and treating obesity, fatty liver and arteriosclerosis.
Cortex Cinnamomi has immunity regulating, blood pressure lowering, analgesic, tranquilizing, anticonvulsive, and anticoagulant effects. Simultaneously, the preparation has the functions of protecting and stimulating insulin and can promote the secretion of insulin of human bodies.
The polygonum multiflorum can enhance the immunologic function of a human body, has the functions of resisting aging, reducing blood fat, resisting bacteria and tumors, improving blood, tonifying liver and kidney, promoting hematopoiesis, preventing atherosclerosis and delaying aging.
The trichosanthes root can clear heat, purge fire, promote salivation, quench thirst, discharge pus and reduce swelling, and clinical experiments prove that the trichosanthes root is a good hypoglycemic medicament.
Radix Puerariae can inhibit the formation of platelet coagulation thrombus. The effective components of the kudzu root, such as puerarin, daidzein and the like, have good effects of reducing blood sugar and blood fat. Puerarin has certain effect of reducing blood sugar level of human body. In addition, puerarin has positive effect on treating diabetic nephropathy.
Red ginseng, pseudo-ginseng, leech, pearl, stiff silkworm, coptis root, cinnamon, tuber fleeceflower root, Mongolian snakegourd root, kudzuvine root, danshen root, dwarf lilyturf tuber, manyflower solomonseal rhizome and hawthorn fruit. The panax notoginseng, the red ginseng, the tuber fleeceflower root, the kudzuvine root, the Mongolian snakegourd root, the siberian solomonseal rhizome and the like are matched with each other, so that the traditional Chinese medicine composition provided by the invention can solve metabolic disorders of diabetic patients while reducing blood sugar, and can fully regulate endocrine and metabolic disorders of organisms. The traditional Chinese medicine composition has the effects of supplementing qi and nourishing yin, promoting the production of body fluid and clearing heat, tonifying kidney and activating blood, can restore the normal function of islet B cells, correct abnormal blood rheological property, reduce blood sugar, eliminate the symptoms of lung deficiency, spleen deficiency and kidney deficiency of a diabetic patient, and can treat diabetes and complications of the diabetic patient.
Further, the traditional Chinese medicine composition comprises the following raw materials in parts by weight: 30-70 parts of red ginseng, 35-65 parts of pseudo-ginseng, 40-60 parts of leech, 30-60 parts of pearl, 40-80 parts of stiff silkworm, 25-75 parts of coptis chinensis, 40-60 parts of cinnamon, 30-70 parts of polygonum multiflorum, 25-75 parts of trichosanthes root, 50-80 parts of kudzuvine root, 45-85 parts of salvia miltiorrhiza, 50-80 parts of dwarf lilyturf tuber, 25-75 parts of rhizoma polygonati and 30-60 parts of hawthorn.
According to the weight parts, the traditional Chinese medicine composition provided by the invention has the effects of tonifying qi and yin, promoting the production of body fluid and clearing heat, tonifying kidney, and promoting blood circulation to remove blood stasis, can improve the immunity of the body, coordinate the functions of viscera, fundamentally improve the physiological function of a diabetic patient, recover the normal functions of islet B cells, achieve the effect of treating both symptoms and root causes, eliminate the symptoms of lung deficiency, spleen deficiency and kidney deficiency of the diabetic patient, and treat diabetes and complications.
Further, the dosage form of the traditional Chinese medicine composition is one of pills, powder, granules or capsules.
A preparation method of a traditional Chinese medicine composition for treating diabetes comprises the following steps:
(1) soaking cortex Cinnamomi, Polygoni Multiflori radix, Trichosanthis radix, radix Puerariae, Saviae Miltiorrhizae radix, radix Ophiopogonis, rhizoma Polygonati and fructus crataegi in water;
(2) decocting the raw materials soaked in the step (1), filtering out residues of the raw materials, concentrating the obtained liquid medicine to a solid state, and crushing to obtain first mixed medicinal powder;
(3) respectively frying pearl and stiff silkworm, mixing the fried pearl and stiff silkworm with red ginseng, pseudo-ginseng, leech, coptis chinensis and cinnamon, and crushing to obtain second mixed medicinal powder;
(4) and mixing the first mixed powder and the second mixed powder, drying, screening, and uniformly stirring to obtain the traditional Chinese medicine composition.
The cinnamon, the fleece-flower root, the trichosanthes root, the kudzu root, the salvia miltiorrhiza, the dwarf lilyturf tuber, the rhizoma polygonati and the hawthorn are added into water for soaking, and then are decocted, concentrated and crushed, so that the effective components in the raw materials can be fully extracted. Parching Margarita and Bombyx Batryticatus, mixing with Ginseng radix Rubri, Notoginseng radix, Hirudo, Coptidis rhizoma and cortex Cinnamomi, and pulverizing to make the raw materials mutually cooperate and support each other to give full play to the drug effect.
Further, the step (1) specifically includes: adding cinnamon, fleece-flower root, trichosanthes root, kudzu root, salvia miltiorrhiza, dwarf lilyturf tuber, rhizoma polygonati and hawthorn into water for soaking, wherein the weight part of the water is 5-10 times of the sum of the weight parts of the cinnamon, the fleece-flower root, the trichosanthes root, the kudzu root, the salvia miltiorrhiza, the dwarf lilyturf tuber, the rhizoma polygonati and the hawthorn, and the soaking time is 1-1.5 hours.
Further, the step (2) specifically includes:
s21: decocting the raw materials soaked in the step (1) for 30-60 minutes at the temperature of 180-;
s22: adding water into the decocted raw materials, decocting for 1-3 times in the decocting mode of S21, filtering out residues of the raw materials, mixing liquid medicines obtained each time, concentrating at the temperature of 120-.
Further, in the step (3), the pearl is fried to crack at the temperature of 120-150 ℃, and the stiff silkworm is fried to golden yellow on the surface.
Parching the pearls with slow fire (120-; the stiff silkworm is fried to be golden yellow by slow fire, so that the drug effect of the stiff silkworm can be fixed, and the stiff silkworm can be absorbed by a human body easily.
Further, the step (4) specifically includes:
mixing the first mixed powder and the second mixed powder, naturally drying in the shade, and sieving with a sieve of 150-200 meshes.
Further, after the step (4), the method further comprises the following steps: the obtained Chinese medicinal composition is sterilized and disinfected by ultraviolet rays.
The prepared traditional Chinese medicine composition is sterilized and disinfected by ultraviolet rays, so that safe medicines are provided for patients.
Compared with the prior art, the invention has the beneficial effects that: under the guidance of the traditional Chinese medicine theory and clinical experience, the traditional Chinese medicine composition is prepared by selecting red ginseng, pseudo-ginseng, leech, pearl, stiff silkworm, coptis, cinnamon, fleece-flower root, trichosanthes root, kudzu root, salvia miltiorrhiza, ophiopogon root, polygonatum and other traditional Chinese medicine raw materials, scientifically proportioning, and treating diabetes, especially II-type diabetes by utilizing the mutual synergy or resistance effect of the raw materials; the invention can obviously reduce the blood sugar of the diabetic, can prevent and treat various complications caused by diabetes and has no toxic or side effect. In addition, the invention also has the functions of regulating endocrine, promoting blood circulation by removing blood stasis and improving the immunity of the diabetic.
Detailed Description
It should be noted that the following detailed description is exemplary and is intended to provide further explanation of the disclosure. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application belongs.
It is noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of example embodiments according to the present application. As used herein, the singular forms also include the plural forms unless the context clearly dictates otherwise, and further, it is understood that when the terms "comprises" and/or "comprising" are used in this specification, they specify the presence of the stated features, steps, operations, devices, components, and/or combinations thereof.
Hereinafter, embodiments of the present invention will be described in detail. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby.
Example 1
Taking the following raw materials in parts by weight: 10 parts of red ginseng, 10 parts of pseudo-ginseng, 10 parts of leech, 10 parts of pearl, 10 parts of stiff silkworm, 10 parts of coptis chinensis, 10 parts of cinnamon, 10 parts of polygonum multiflorum, 10 parts of trichosanthes root, 10 parts of kudzuvine root, 10 parts of salvia miltiorrhiza, 10 parts of radix ophiopogonis, 10 parts of rhizoma polygonati and 10 parts of hawthorn.
The method comprises the following steps:
(1) soaking cortex Cinnamomi, Polygoni Multiflori radix, Trichosanthis radix, radix Puerariae, Saviae Miltiorrhizae radix, radix Ophiopogonis, rhizoma Polygonati and fructus crataegi in water;
(2) decocting the raw materials soaked in the step (1), filtering out residues of the raw materials, concentrating the obtained liquid medicine to a solid state, and crushing to obtain first mixed medicinal powder;
(3) respectively frying pearl and stiff silkworm, mixing the fried pearl and stiff silkworm with red ginseng, pseudo-ginseng, leech, coptis chinensis and cinnamon, and crushing to obtain second mixed medicinal powder;
(4) and mixing the first mixed powder and the second mixed powder, drying, screening, and uniformly stirring to obtain the traditional Chinese medicine composition.
Example 2
Taking the following raw materials in parts by weight: 50 parts of red ginseng, 50 parts of pseudo-ginseng, 50 parts of leech, 50 parts of pearl, 50 parts of stiff silkworm, 50 parts of coptis chinensis, 50 parts of cinnamon, 50 parts of polygonum multiflorum, 50 parts of trichosanthes root, 50 parts of kudzuvine root, 50 parts of salvia miltiorrhiza, 50 parts of radix ophiopogonis, 50 parts of rhizoma polygonati and 50 parts of hawthorn.
The method comprises the following steps:
(1) soaking cinnamon, polygonum multiflorum, trichosanthes root, kudzu root, salvia miltiorrhiza, ophiopogon root, polygonatum and hawthorn in water, wherein the weight part of the water is 5 times of the sum of the weight parts of the cinnamon, the polygonum multiflorum, the trichosanthes root, the kudzu root, the salvia miltiorrhiza, the ophiopogon root, the polygonatum and the hawthorn;
(2) decocting the raw materials soaked in the step (1) at 180 ℃ for 30 minutes, then continuing to decoct for 40 minutes at 120 ℃, and filtering to obtain liquid medicine and the decocted raw materials; adding water into the decocted raw materials, decocting for 2 times according to the previous decocting mode, filtering out residues of the raw materials, mixing liquid medicines obtained each time, concentrating at 150 ℃, concentrating to a solid state, and crushing to obtain first mixed medicinal powder;
(3) parching Margarita to crack at 120 deg.C, parching Bombyx Batryticatus to golden yellow surface, mixing parched Margarita and Bombyx Batryticatus with Ginseng radix Rubri, Notoginseng radix, Hirudo, Coptidis rhizoma and cortex Cinnamomi, and pulverizing to obtain a second mixed powder;
(4) and mixing the first mixed powder and the second mixed powder, naturally drying in the shade, and sieving by a 150-mesh sieve to obtain the traditional Chinese medicine composition.
Example 3
Taking the following raw materials in parts by weight: 100 parts of red ginseng, 100 parts of pseudo-ginseng, 100 parts of leech, 100 parts of pearl, 100 parts of stiff silkworm, 100 parts of coptis, 100 parts of cinnamon, 100 parts of polygonum multiflorum, 100 parts of trichosanthes root, 100 parts of kudzuvine root, 100 parts of salvia miltiorrhiza, 100 parts of radix ophiopogonis, 100 parts of rhizoma polygonati and 100 parts of hawthorn.
The method comprises the following steps:
(1) adding cinnamon, tuber fleeceflower root, Mongolian snakegourd root, kudzuvine root, danshen root, dwarf lilyturf tuber, manyflower solomonseal rhizome and hawthorn fruit into water for soaking, wherein the weight of the water is 10 times of the sum of the weight of the cinnamon, the tuber fleeceflower root, the Mongolian snakegourd root, the kudzuvine root, the danshen root, the dwarf lilyturf tuber, the;
(2) decocting the raw materials soaked in the step (1) for 50 minutes at 200 ℃, then continuously decocting for 40 minutes at 150 ℃, and filtering to obtain liquid medicine and the decocted raw materials; adding water into the decocted raw materials, decocting for 3 times according to the previous decocting mode, filtering out residues of the raw materials, mixing liquid medicines obtained each time, concentrating at 140 ℃, concentrating to a solid state, and crushing to obtain first mixed medicinal powder;
(3) parching Margarita to crack at 130 deg.C, parching Bombyx Batryticatus to golden surface, mixing parched Margarita and Bombyx Batryticatus with Ginseng radix Rubri, Notoginseng radix, Hirudo, Coptidis rhizoma and cortex Cinnamomi, and pulverizing to obtain a second mixed powder;
(4) and mixing the first mixed powder and the second mixed powder, naturally drying in the shade, and sieving by a 200-mesh sieve to obtain the traditional Chinese medicine composition.
Alternatively, in the above embodiments of the present invention, the mass per 1 part is specifically 1 g.
The following six cases, cases 1 and 2 were administered with the Chinese medicinal composition provided in this example 1, cases 3 and 4 were administered with the Chinese medicinal composition provided in this example 2, and cases 5 and 6 were administered with the Chinese medicinal composition provided in this example 3.
Case 1: sunzhi, male, age 49, type II diabetic. Fasting blood glucose before taking the drug of the invention: 8.13mmol/l, 10.5mmol/l of blood sugar after meal, metformin, glimepiride and the like are taken once, but the curative effect is poor. After three months of treatment with the treatment 1, the blood sugar was reduced, and the fasting blood sugar was measured to be 6.8mmol/l, and the blood sugar 2 hours after meal was 7.5 mmol/l.
Case 2: wangzhi, female, age 41, type II diabetic. Fasting blood glucose before taking the drug of the invention: 8.82mmol/l, 11.5mmol/l of blood sugar after meal, miglitol tablet, gold and the like are taken once, but the blood sugar is not reduced to the normal level. After three months of treatment with this example 1, fasting plasma glucose was measured at 7.1mmol/l and 2 hours after meal at 8.4 mmol/l.
Case 3: plum, male, 46 years old, type II diabetic, general weakness, vexation, headache, body emaciation, general fatigue, sleepiness, fasting blood glucose of 10.6mmol/l, blood glucose 14.1mmol/l two hours after meal, three months after the treatment of this example 2, blood glucose reduction, fasting blood glucose of 5.8mmol/l, 2 hours after meal, blood glucose of 6.9 mmol/l.
Case 4: Wu-Shi, women, 55 years old, type II diabetic. Fasting blood glucose at the time of treatment: 11.1mmol/l, postprandial blood glucose 16.5 mmol/l. After three months of treatment according to example 2, the blood glucose was reduced and measured as 6.6mmol/l fasting blood glucose and 7.3mmol/l 2 hours after meal.
Case 5: li Yi, male, type II diabetes mellitus patient 39 years old, normal limb weakness, vexation and headache, body emaciation, normal feelings of fatigue and sleepiness, fasting blood sugar 10.6mmol/l measured, blood sugar 14.1mmol/l two hours after meal, blood sugar drop measured after three months of treatment in this example 3, fasting blood sugar 5.8mmol/l measured, and blood sugar 6.9mmol/l 2 hours after meal.
Case 6: male, age 46, type ii diabetic. Fasting blood glucose at the time of treatment: 9.1mmol/l, postprandial blood glucose 11.5 mmol/l. After 3 months in this example, the blood glucose was decreased, and the fasting blood glucose was measured to be 6.6mmol/l, and the blood glucose 2 hours after meal was measured to be 7.3 mmol/l.
After the patients take the traditional Chinese medicine composition provided by the invention, the blood sugar of all the patients is reduced to different degrees according to the improvement degree of physical symptoms of the patients, and the blood sugar can be maintained at a normal level after the patients take the traditional Chinese medicine composition for a certain time. Therefore, the invention has obvious effect of treating diabetes. And the treatment effect of example 2 was the best.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (9)
1. The traditional Chinese medicine composition for treating diabetes is characterized by comprising the following raw materials in parts by weight: 10-100 parts of red ginseng, 10-100 parts of pseudo-ginseng, 10-100 parts of leech, 10-100 parts of pearl, 10-100 parts of stiff silkworm, 10-100 parts of coptis chinensis, 10-100 parts of cinnamon, 10-100 parts of polygonum multiflorum, 10-100 parts of trichosanthes root, 10-100 parts of radix puerariae, 10-100 parts of salvia miltiorrhiza, 10-100 parts of radix ophiopogonis, 10-100 parts of rhizoma polygonati and 10-100 parts of hawthorn.
2. The traditional Chinese medicine composition for treating diabetes according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 30-70 parts of red ginseng, 35-65 parts of pseudo-ginseng, 40-60 parts of leech, 30-60 parts of pearl, 40-80 parts of stiff silkworm, 25-75 parts of coptis chinensis, 40-60 parts of cinnamon, 30-70 parts of polygonum multiflorum, 25-75 parts of trichosanthes root, 50-80 parts of kudzuvine root, 45-85 parts of salvia miltiorrhiza, 50-80 parts of radix ophiopogonis, 25-75 parts of rhizoma polygonati and 30-60 parts of hawthorn.
3. The traditional Chinese medicine composition for treating diabetes according to claim 1 or 2, wherein the dosage form of the traditional Chinese medicine composition is one of pills, powder, granules or capsules.
4. A method for preparing the traditional Chinese medicine composition for treating diabetes mellitus of any one of claims 1 to 3, which is characterized by comprising the following steps:
(1) soaking cortex Cinnamomi, Polygoni Multiflori radix, Trichosanthis radix, radix Puerariae, Saviae Miltiorrhizae radix, radix Ophiopogonis, rhizoma Polygonati and fructus crataegi in water;
(2) decocting the raw materials soaked in the step (1), filtering out residues of the raw materials, concentrating the obtained liquid medicine to a solid state, and crushing to obtain first mixed medicinal powder;
(3) respectively frying pearl and stiff silkworm, mixing the fried pearl and stiff silkworm with red ginseng, pseudo-ginseng, leech, coptis chinensis and cinnamon, and crushing to obtain second mixed medicinal powder;
(4) and mixing the first mixed powder and the second mixed powder, drying, screening, and uniformly stirring to obtain the traditional Chinese medicine composition.
5. The preparation method of the traditional Chinese medicine composition for treating diabetes as claimed in claim 4, is characterized in that: the step (1) specifically comprises:
adding cinnamon, fleece-flower root, trichosanthes root, kudzu root, salvia miltiorrhiza, dwarf lilyturf tuber, rhizoma polygonati and hawthorn into water for soaking, wherein the weight part of the water is 5-10 times of the sum of the weight parts of the cinnamon, the fleece-flower root, the trichosanthes root, the kudzu root, the salvia miltiorrhiza, the dwarf lilyturf tuber, the rhizoma polygonati and the hawthorn, and the soaking time is 1-1.5 hours.
6. The preparation method of the traditional Chinese medicine composition for treating diabetes as claimed in claim 5, is characterized in that: the step (2) specifically comprises:
s21: decocting the raw materials soaked in the step (1) for 30-60 minutes at the temperature of 180-;
s22: adding water into the decocted raw materials, decocting for 1-3 times in the decocting mode of S21, filtering out residues of the raw materials, mixing liquid medicines obtained each time, concentrating at the temperature of 120-.
7. The preparation method of the traditional Chinese medicine composition for treating diabetes as claimed in claim 6, is characterized in that: in the step (3), the stir-frying mode is,
parching Margarita at 150 deg.C at 120-.
8. The preparation method of the traditional Chinese medicine composition for treating diabetes as claimed in claim 7, is characterized in that: the step (4) specifically comprises:
mixing the first mixed powder and the second mixed powder, naturally drying in the shade, and sieving with a sieve of 150-200 meshes.
9. The method for preparing a Chinese medicinal composition for treating diabetes according to claims 4-7, characterized in that, after the step (4), the method further comprises:
the obtained Chinese medicinal composition is sterilized and disinfected by ultraviolet rays.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911181261.7A CN110787258A (en) | 2019-11-27 | 2019-11-27 | A Chinese medicinal composition for treating diabetes, and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911181261.7A CN110787258A (en) | 2019-11-27 | 2019-11-27 | A Chinese medicinal composition for treating diabetes, and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110787258A true CN110787258A (en) | 2020-02-14 |
Family
ID=69446411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911181261.7A Pending CN110787258A (en) | 2019-11-27 | 2019-11-27 | A Chinese medicinal composition for treating diabetes, and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110787258A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1349823A (en) * | 2001-10-25 | 2002-05-22 | 王同生 | Making process of enzyme degrading oral liquid |
| CN101934030A (en) * | 2010-08-28 | 2011-01-05 | 郑沛 | Medicinal composition for treating symptom-complex of excessive eating (diabetes) and method for preparing same |
| CN103083531A (en) * | 2011-10-27 | 2013-05-08 | 彭竹妍 | Drug for treating diabetes |
-
2019
- 2019-11-27 CN CN201911181261.7A patent/CN110787258A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1349823A (en) * | 2001-10-25 | 2002-05-22 | 王同生 | Making process of enzyme degrading oral liquid |
| CN101934030A (en) * | 2010-08-28 | 2011-01-05 | 郑沛 | Medicinal composition for treating symptom-complex of excessive eating (diabetes) and method for preparing same |
| CN103083531A (en) * | 2011-10-27 | 2013-05-08 | 彭竹妍 | Drug for treating diabetes |
Non-Patent Citations (2)
| Title |
|---|
| 付志平: "从脾论治糖尿病68例体会", 江西中医药, vol. 33, no. 04, 21 August 2002 (2002-08-21), pages 1 * |
| 张育清: "益气养阴活血为法拟方合达美康治疗老年糖尿病疗效观察", 安徽中医临床杂志, vol. 14, no. 06, 28 December 2002 (2002-12-28), pages 451 - 452 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102172385B (en) | A kind of Chinese medicine preparation with enhancing immunity, blood sugar lowering and effect for reducing blood fat | |
| CN102579610B (en) | Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof | |
| CN104815166A (en) | Traditional Chinese medicine composition for treating diabetes as well as preparation and application of traditional Chinese medicine composition | |
| CN102488830B (en) | Pharmaceutical composition for lowering blood sugar | |
| CN101279034B (en) | Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof | |
| CN103705578B (en) | There is blood fat reducing and Chinese medicine preparation suppressing blood glucose rising effect and preparation method thereof | |
| CN100388945C (en) | Fatty liver treating notoginseng prepn and its prepn process | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN103007159B (en) | Chinese medicinal preparation for correcting pancreas islet function | |
| CN101843843A (en) | Chinese medicament for treating diabetes | |
| CN1899482A (en) | Medicine for treating chronic glomerular nephritis and its producing method | |
| CN110787258A (en) | A Chinese medicinal composition for treating diabetes, and its preparation method | |
| CN110339293A (en) | A kind of arteries and veins gel resin capsule formula and preparation process | |
| CN104800600A (en) | Medicine for treating hypertension | |
| CN110464803A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood pressure | |
| CN114588228B (en) | Composition for treating type 2 diabetes | |
| CN107412679A (en) | Detoxifying health-care product and its preparation method and application | |
| CN102100853B (en) | Traditional Chinese medicine for treating gout and preparation method thereof | |
| CN102309635B (en) | Traditional Chinese medicine preparation for treating diabetes | |
| CN105194296A (en) | Medicine composition for treating heart diseases | |
| CN105311413A (en) | Traditional Chinese medicinal composition containing folium artemisiae argyi for treating diabetic nephropathy and preparation method of traditional Chinese medicinal composition | |
| CN113384644A (en) | A Chinese medicinal composition and its preparation method | |
| CN104645247A (en) | Traditional Chinese medicine preparation for treating hepatolenticular degeneration and preparation method of traditional Chinese medicine preparation | |
| CN110755551A (en) | Medicine for treating diabetes | |
| CN117618521A (en) | Traditional Chinese medicine formula for treating type II diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |